Drug Chatter -- Tracking biopharma stock chatter

💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch

Profile for TRACON Pharmaceuticals, Inc. (TCON)

« Back to company index

TCON Chatter Timeline

Stock Ticker for TCON

Most Active Tweeters for TCON

UserTweets
@StckPro 4
@Beeken_health 2
@FlashAlert_me 2
@Tickeron 2
@stonkmooncom 1

Recent Tweets for TCON

newsfilterio @newsfilterio
Revisiting Tracon Pharmaceuticals $TCON https://t.co/SP1PMJC3qJ
November 30th 2022, 6:11am
SeekingAlpha @SeekingAlpha
$TCON - Revisiting Tracon Pharmaceuticals. https://t.co/Zvu4t7iXsn #economy #markets #investing
November 30th 2022, 6:11am
WallStBreaking @WallStBreaking
Tracon Pharmaceuticals announces amended ENVASARC protocol $TCON
November 24th 2022, 7:11am
Tickeron @Tickeron
$TCON in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/n6gUBuTcbC
November 23rd 2022, 5:11pm
insider_cyborg @insider_cyborg
? New Regular Insider Purchase Ticker: $TCON Sector: Healthcare Market Cap: 33 mm. Insider Title: Pres, CEO Traded… https://t.co/9sy90eNiIY
November 23rd 2022, 1:11pm
Tickeron @Tickeron
$TCON's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/E4g0JrGbnh
November 23rd 2022, 2:11am
StckPro @StckPro
$TCON NEW ARTICLE : TRACON Pharmaceuticals (TCON) Receives a Buy from Maxim Group https://t.co/TSuFpXDMYA Get all t… https://t.co/icR98EOLHI
November 22nd 2022, 2:11pm
InsiderPurchase @InsiderPurchase
$TCON - Tracon Pharmaceuticals, Inc. #TraconPharmaceuticals Theuer Charles (Pres, CEO) purchases +13,900 shares for… https://t.co/S2bUKEUb86
November 22nd 2022, 11:11am
InsiderPeek @InsiderPeek
$TCON CEO Theuer Charles bought 13.9k shares for $19.6k (ownership up 4.69%) https://t.co/w2HRMKED6s https://t.co/IOQtditpCX
November 22nd 2022, 11:11am
mediasentiment @mediasentiment
$TCON new alert at https://t.co/A7qrDaJkzw #stocks #daytrading #NYSE #NASDAQ #market 254
November 22nd 2022, 11:11am
FintelAlerts @FintelAlerts
Insider Charles Theuer reports buying 13,900 shares of $TCON for a total cost of $19,599.00 https://t.co/gD5YapXfxi
November 22nd 2022, 11:11am
FlashAlert_me @FlashAlert_me
$TCON [15s. delayed] filed SEC form 4: President and CEO THEUER CHARLES: Acquired 13,900 of Common Stock at price… https://t.co/VQ8DxnQGSn
November 22nd 2022, 11:11am
StckPro @StckPro
$TCON NEW ARTICLE : H.C. Wainwright Sticks to Its Buy Rating for TRACON Pharmaceuticals (TCON)… https://t.co/uja0ZYIXa2
November 21st 2022, 3:11pm
MarcJacksonLA @MarcJacksonLA
$TCON TRACON Pharmaceuticals doses first patient in drug trial to treat malignant tumours https://t.co/GQTIl5y9RS @TRACONPharma #TCON
November 21st 2022, 3:11pm
Beeken_health @Beeken_health
$TCON - TRACON Pharmaceuticals doses first patient in drug trial to treat malignant tumours https://t.co/YksEUvrRd8
November 21st 2022, 3:11pm
proactive_NA @proactive_NA
$TCON TRACON Pharmaceuticals doses first patient in drug trial to treat malignant tumours https://t.co/KBOB7xoHLx @TRACONPharma #TCON
November 21st 2022, 1:11pm
StckPro @StckPro
$TCON NEW ARTICLE : TRACON Pharmaceuticals doses first patient in drug trial to treat malignant tumours… https://t.co/ShzQICANUw
November 21st 2022, 1:11pm
PennyStockNews5 @PennyStockNews5
$TCON ? Sentiments: title 0.0 | summary -0.4767 Pre-Price: 0,"toCurrency" | Bid: 1.31 | Ask: 1.88 Volume: 112,620 https://t.co/k3tD3mpAcg
November 21st 2022, 1:11pm
StckPro @StckPro
$TCON NEW ARTICLE : TRACON Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Trial of YH001 in Combina… https://t.co/55NsNqPlJz
November 21st 2022, 1:11pm
quantisnow @quantisnow
$TCON ? TRACON Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Trial of YH001 in Combination with En… https://t.co/1JphBBI5XB
November 21st 2022, 1:11pm
FlashAlert_me @FlashAlert_me
$TCON [15s. delayed]: Issued Press Release on November 21, 08:00:00: TRACON Pharmaceuticals Announces Dosing of Fir… https://t.co/iGWXqVnlFR
November 21st 2022, 1:11pm
Beeken_health @Beeken_health
$TCON - TRACON Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Trial of YH001 in Combination with En… https://t.co/dmJTC3mo8a
November 21st 2022, 1:11pm
stonkmooncom @stonkmooncom
$TCON 2022-11-21 08:00 ET TRACON Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Trial of YH001 i… https://t.co/nW3xYrCYGT
November 21st 2022, 1:11pm
Tradesense_me @Tradesense_me
$TCON ? ? Press Release TRACON Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Trial of YH001 in Co… https://t.co/eYqigP0bb9
November 21st 2022, 1:11pm
StockNewsBot2 @StockNewsBot2
$TCON TRACON Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Trial of YH001 in Combination with Enva… https://t.co/ckUXIXk8Mm
November 21st 2022, 1:11pm
FastestAlert @FastestAlert
$TCON TRACON Pharmaceuticals Announces Dosing Of First Patient In Phase 1/2 Trial Of YH001 In Combination With Enva… https://t.co/GukNc5crDf
November 21st 2022, 1:11pm
stock_titan @stock_titan
$TCON TRACON Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Trial of YH001 in Combination with Enva… https://t.co/ncbevkVLbV
November 21st 2022, 1:11pm
StckPro @StckPro
$TCON NEW ARTICLE : Maxim Group Remains a Buy on TRACON Pharmaceuticals (TCON) https://t.co/87hLOFHtsv Get all the… https://t.co/7ypqMN5Phw
November 16th 2022, 8:11pm
shortablestocks @shortablestocks
$TCON is short sale restricted for 2022-11-16. https://t.co/uBMmXu4UUb
November 16th 2022, 2:11pm
StckPro @StckPro
$TCON NEW ARTICLE : JonesTrading Sticks to Its Buy Rating for TRACON Pharmaceuticals (TCON) https://t.co/iyQfaFKlUm… https://t.co/ybAxcCjL0k
November 15th 2022, 10:11pm
StckPro @StckPro
$TCON NEW ARTICLE : H.C. Wainwright Keeps Their Buy Rating on TRACON Pharmaceuticals (TCON) https://t.co/CjYF0QiQvr… https://t.co/jLfb16loNL
November 15th 2022, 11:11am
newsfilterio @newsfilterio
Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC $TCON https://t.co/a4EAMPbSpV
November 15th 2022, 8:11am
StckPro @StckPro
$TCON NEW ARTICLE : TRACON Pharmaceuticals, Inc. (TCON) Q3 2022 Earnings Call Transcript https://t.co/8sh5ApAMgZ Ge… https://t.co/mYY6GBbITO
November 15th 2022, 3:11am
SeekingAlpha @SeekingAlpha
$TCON - TRACON Pharmaceuticals, Inc. (TCON) Q3 2022 Earnings Call Transcript. https://t.co/CYbBztEAco #markets #business #finance
November 15th 2022, 3:11am
MarcJacksonLA @MarcJacksonLA
$TCON TRACON Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update https://t.co/4pTDIuZoDv
November 15th 2022, 2:11am
newsfilterio @newsfilterio
TRACON Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update $TCON https://t.co/kJlG7zkkeu
November 15th 2022, 2:11am
Tickeron @Tickeron
$TCON enters a Downtrend because Momentum Indicator dropped below the 0 level on November 3, 2022. View odds for th… https://t.co/mBkS1YHX14
November 14th 2022, 11:11pm
Beeken_health @Beeken_health
$TCON - TRACON Pharmaceuticals ends 3Q with $17M cash and equivalents to fund operations into mid-2023 https://t.co/AtPNhJwosx
November 14th 2022, 11:11pm
investor_feed @investor_feed
$TCON 10-Q TRACON Pharmaceuticals (14 Nov, 5:01pm) ? 2022 Q3 Earnings https://t.co/sMwTlbMoXN #TCON #10Q… https://t.co/Ayy2LSMRwx
November 14th 2022, 10:11pm
StckPro @StckPro
$TCON NEW ARTICLE : TRACON Pharmaceuticals ends 3Q with $17M cash and equivalents to fund operations into mid-2023… https://t.co/kMzJb57mdr
November 14th 2022, 9:11pm
semodough @semodough
$TCON Enrollment in the ENVASARC Phase 2 pivotal trial continues to be ahead of schedule and we look forward to rep… https://t.co/pLVylfARBo
November 14th 2022, 9:11pm
proactive_NA @proactive_NA
$TCON TRACON Pharmaceuticals ends 3Q with $17M cash and equivalents to fund operations into mid-2023… https://t.co/1qXFRYVfAp
November 14th 2022, 9:11pm
beachbumcapital @beachbumcapital
RT @semodough: @BiotechElmo $TCON TRACON disclosed that the International Court of Arbitration of the International Chamber of Commerce (IC…
November 14th 2022, 9:11pm
zipjet @zipjet
@semodough @BiotechElmo $TCON Enrollment in the ENVASARC Phase 2 pivotal trial continues to be ahead of schedule a… https://t.co/OrY1Lak235
November 14th 2022, 9:11pm
StckPro @StckPro
$TCON NEW ARTICLE : TRACON Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Upda… https://t.co/nR1SYvwehI
November 14th 2022, 9:11pm
zipjet @zipjet
@semodough @BiotechElmo $TCON ... ICC Tribunal that it is far along in its deliberations but invited additional inf… https://t.co/wLDEqUkXDt
November 14th 2022, 9:11pm
FlashAlert_me @FlashAlert_me
$TCON [15s. delayed, acc.~90%, always check] Earnings Release November 14, 16:02:00: Q3: GAAP EPS of -$0.30 https://t.co/m3uipmvyBg
November 14th 2022, 9:11pm
Tradesense_me @Tradesense_me
$TCON ? ? Press Release TRACON Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporat… https://t.co/OFKYOzLDJI
November 14th 2022, 9:11pm
stonkmooncom @stonkmooncom
$TCON 2022-11-14 16:02 ET TRACON Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corp… https://t.co/MYayvGoaQ1
November 14th 2022, 9:11pm
FlashAlert_me @FlashAlert_me
$TCON [15s. delayed] filed form 8-K on November 14, 16:01:09 https://t.co/joXJvfxyKn
November 14th 2022, 9:11pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.